Stock Events

Stock Events

Immunovia AB 

$0.02
4
+$0+0% Wednesday 20:00

Statistics

Day High
0.15
Day Low
0.15
52W High
0.15
52W Low
0.02
Volume
325
Avg. Volume
7
Mkt Cap
6.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.01
-0.01
-0.01
-0
Expected EPS
-0.0032719304
Actual EPS
N/A

Financials

-24,571.85%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
182,716.44Revenue
-44.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMMVF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences Corp. offers cancer screening and diagnostic tests, competing directly in the early detection market where Immunovia also operates.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health provides liquid biopsy tests for cancer diagnostics, overlapping with Immunovia's focus on early cancer detection using blood-based biomarkers.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG develops diagnostic tools and technologies for detecting various diseases including cancer, similar to Immunovia's diagnostic solutions.
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. offers genomic sequencing solutions used in cancer and other health diagnostics, competing in the broader market of molecular diagnostics.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, competing with Immunovia in the field of precision medicine and diagnostics.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics incorporates advanced diagnostics for conditions including cancer, directly competing with Immunovia's diagnostic tests.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. specializes in clinical diagnostics and life science research, offering products that compete in the diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics, Inc. focuses on genetic testing to detect cancer and other diseases, competing with Immunovia's genomic and proteomic testing approaches.
Myriad Genetics
MYGN
Mkt Cap748.08M
Myriad Genetics, Inc. provides molecular diagnostic tests that assess the risk of developing cancer, competing with Immunovia's focus on early detection and risk assessment.

About

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Show more...
CEO
Mr. Jeff Borcherding
Employees
9
Country
SE
ISIN
SE0006091997

Listings

LSE
GB
0G8X.LSE
ST
SE
IMMNOV.ST
F
DE
1YR.F
OTC Link
US
IMMVF

0 Comments

Share your thoughts

FAQ

What is Immunovia AB stock price today?▼
The current price of IMMVF is $0.02 USD — it has increased by +0% in the past 24 hours. Watch Immunovia AB stock price performance more closely on the chart.
What is Immunovia AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Immunovia AB stocks are traded under the ticker IMMVF.
What is Immunovia AB market cap?▼
Today Immunovia AB has the market capitalization of 6.12M
When is the next Immunovia AB earnings date?▼
Immunovia AB is going to release the next earnings report on May 07, 2026.
What is Immunovia AB revenue for the last year?▼
Immunovia AB revenue for the last year amounts to 182,716.44 USD.
What is Immunovia AB net income for the last year?▼
IMMVF net income for the last year is -44.9M USD.
How many employees does Immunovia AB have?▼
As of April 02, 2026, the company has 9 employees.
In which sector is Immunovia AB located?▼
Immunovia AB operates in the Health Care sector.
When did Immunovia AB complete a stock split?▼
The last stock split for Immunovia AB was on May 10, 2018 with a ratio of 1:3.2.
Where is Immunovia AB headquartered?▼
Immunovia AB is headquartered in Lund, SE.